当前位置:Public Access >页面
Chinese/English
A preliminary clinical trial on the safety and efficacy of high-purity human NK cell (hpNK) injection combined with rituximab in the treatment of CD20-positive diffuse large B-cell lymphoma (CD20+ r/r DLBCL)
Filter Options
Patient No. Patient Name Patient Gender
Sitting Education Date of enrollment FromTo
       More Options
Patient No Gender Date of enrollment Sitting Creater Operate
NO participants recorded。